Early Recognition, Accurate Diagnosis, and Appropriate Treatment Selection in Psoriatic Arthritis
Rheumatology
Curriculum:
Psoriatic Arthritis: Optimizing Approaches to Recognition and Management
Psoriatic Arthritis: Optimizing Approaches to Recognition and Management
Credits:
0.5 AMA PRA Category 1 Credit(s) ™
0.5 AMA PRA Category 1 Credit(s) ™
Launch Date:
February 09, 2017
February 09, 2017
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Dermatologists and rheumatologists
Relevant Terms:
Psoriatic arthritis
Jose U. Scher, MD
Jose U. Scher, MD
Assistant Professor Medicine (Rheumatology)
New York University School of Medicine
New York, NY
Bio
Jose U. Scher, MD, is assistant professor in the Department of Medicine at New York University (NYU) Langone Medical Center. He serves as director of the Arthritis Clinic at NYU-Hospital for Joint Diseases, the Psoriatic Arthritis Center at NYU Langone Medical Center, and the Microbiome Center for Rheumatology and Autoimmunity at NYU School of Medicine. As the director of the Psoriatic Arthritis Center, Dr. Scher oversees patient care, education, and translational research initiatives in psoriatic arthritis. His main area of research is related to the role of the human microbiome in autoimmune and rheumatic disease, specifically in psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Joseph F. Merola, MD, MMSc
Joseph F. Merola, MD, MMSc
Assistant Professor
Harvard Medical School
Boston, MA
Bio
.jpg)
Joseph F. Merola, MD, MMSc, is an assistant professor at Harvard Medical School. He is also director of the Clinical Unit for Research Innovation and Trials (CUReIT), co-director of the Center for Skin and Related Musculoskeletal Diseases, and associate program director for the combined internal medicine-dermatology residency training program. In addition, Dr. Merola is on the medical board of the National Psoriasis Foundation. His clinical and research interests are focused on psoriasis and psoriatic arthritis. Dr. Merola received an MD from the New York University (NYU) School of Medicine and a MMSc from Harvard Medical School. He completed dermatology training and was chief resident at the NYU School of Medicine, and he trained in internal medicine and rheumatology at Brigham and Women’s Hospital. Dr. Merola is board-certified in internal medicine, dermatology, and rheumatology.
Andrea L. Neimann, MD, MSCE
Andrea L. Neimann, MD, MSCE
Assistant Professor of Dermatology
Director, Dermatology Clinical Studies Unit
Ronald O. Perelman Department of Dermatology
New York University School of Medicine
New York, NY
Bio
Andrea L. Neimann, MD, MSCE, is director of the Dermatology Clinical Studies Unit and assistant professor of dermatology at New York University School of Medicine. She received her MD from the University of the Witwatersrand in Johannesburg, South Africa, and her MSCE certification in epidemiology from the University of Pennsylvania in Philadelphia. She completed her residency at the Albert Einstein College of Medicine in New York City. In addition to precepting dermatology residents at NYU’s psoriasis and psoriatic arthritis clinic, Dr. Neimann has co-authored dozens of articles, book chapters, abstracts, letters, and posters. She is a member of the American Academy of Dermatology and Fellow of the American College of Physicians.
| 1. | Differentiate between psoriatic arthritis (PsA) and other arthritides to ensure early and accurate diagnosis of PsA | 2. | Appropriately incorporate the various disease modifying agents into the management of patients with PsA taking into consideration patient comorbidities |
| 3. | Utilize effective communication and collaboration techniques to foster clinical care coordination among care team members | 4. | Integrate shared decision-making techniques to improve patients' understanding of the risks and benefits of their treatments and to allow them to participate in healthcare decisions |
| 1. | Differentiate between psoriatic arthritis (PsA) and other arthritides to ensure early and accurate diagnosis of PsA |
| 2. | Appropriately incorporate the various disease modifying agents into the management of patients with PsA taking into consideration patient comorbidities |
| 3. | Utilize effective communication and collaboration techniques to foster clinical care coordination among care team members |
| 4. | Integrate shared decision-making techniques to improve patients' understanding of the risks and benefits of their treatments and to allow them to participate in healthcare decisions |
PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and RMEI Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The University of Cincinnati designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and RMEI Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The University of Cincinnati designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Joint Providership Statement
This CME activity is jointly provided by the University of Cincinnati and RMEI Medical Education, LLC.
DISCLOSURE OF CONFLICTS OF INTEREST
According to the disclosure policy of the University of Cincinnati College of Medicine, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.
According to the disclosure policy of the University of Cincinnati College of Medicine, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Jose U. Scher, MD, has affiliations with AbbVie and Novartis (Consulting Fees); and Janssen (Advisory Board).
- Joseph F. Merola, MD, MMSc, has affiliations with AbbVie, Amgen, Biogen IDEC, Eli Lilly, Janssen, Mallinckrodt, Novartis, and Pfizer (Advisory Board); Biogen IDEC, ClearView, Eli Lilly, Kiniksa, Momenta, and Novartis (Consulting Fees); Biogen IDEC (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or Their Agents); and AbbVie (Speaker’s Bureau).
- Andrea L. Neimann, MD, MSCE, has affiliations with Janssen and Valeant (Advisory Board); AbbVie, Amgen, Johnson & Johnson, and Pfizer (Self/Spouse Royalty); and Amgen and Janssen (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or Their Agents).
University of Cincinnati
- Susan P. Tyler, MEd, CMP, CHCP, CME Director, has no affiliations with commercial interests relative to the content to disclose.
- Rick Ricer, MD, CME Physician Reviewer, has no affiliations with commercial interests relative to the content to disclose.
- Deborah Cole, BS, Program Coordinator, has no affiliation with commercial interest relative to the content to disclose.
RMEI Medical Education, LLC
- Joanne M. Faysal, MS, has no affiliations with commercial interests relative to the content to disclose.
- Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests relative to the content to disclose
- Amy Reeve has no affiliations with commercial interests relative to the content to disclose.
DISCLAIMER
The opinions expressed during the enduring activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
DISCLOSURE OF UNLABELED USE
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Estimated time to complete: 0.5 hours
Medium: Internet
Medium: Internet
FEE INFORMATION
There is no fee for this educational activity.
COMMERCIAL SUPPORT
This activity is supported by independent educational grants from AbbVie, Lilly, and UCB.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 0.5 AMA PRA Category 1 Credits™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the activity post-test and evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. You must score 70% or higher on the post-test to receive credit for this activity. Participants have three attempts to successfully pass the post-test.
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above |
